Mednet Logo
HomeMedical OncologyQuestion

What is your preferred approach to metastatic PDL1 negative TNBC?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Brigham and Women's Hospital and Dana-Farber Cancer Institute

I usually treat mTNBC (that are PL-D1 negative and BRCAwt) with single agent chemotherapy in the first line setting. However, there are some exceptions in which I would consider starting with a chemo doublet. In the setting of young age, good PS, high disease burden, and symptomatic patients with ra...

Register or Sign In to see full answer